Penrhyn Covid-19 Response Team
Covid-19 Clinical Lead - Dr Toyin Oremakinde
Covid-19 Admin Lead – Mrs Suzia Riasat
Covid-19 Social Prescriber – Ms Arevik Mkrttchian
For any support and help for shielding patient please direct your queries to “Penrhyn Covid-19 Response Team” at firstname.lastname@example.org
Extremely vulnerable people who should shield from Covid-19
If you are a patient looking for shielding advice, visit the shielded patient pages on https://digital.nhs.uk/coronavirus/shielded-patient-list
If you are already on the list and require extra support, you can register on gov.uk
Patients who are at high risk of developing complications from coronavirus (COVID-19) infection are identified by the following criteria
Solid organ transplant recipients.
People with specific cancers:
people with cancer who are undergoing active chemotherapy
people with lung cancer who are undergoing radical radiotherapy
people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
people having immunotherapy or other continuing antibody treatments for cancer
people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary (COPD).
People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as Severe combined immunodeficiency (SCID), homozygous sickle cell).
People on immunosuppression therapies sufficient to significantly increase risk of infection.
Women who are pregnant with significant heart disease, congenital or acquired.
For any issues or concerns please contact our dedicated
Shielded patient list: transparency notice
Please see https://digital.nhs.uk/coronavirus/shielded-patient-list/shielded-patient-list-transparency-notice